Report: Biogeneric approval may not drop prices immediately

10/9/2009 | Drug Topics

If legislation allows the development of biogeneric drugs, analysts say brand-name manufacturers still could remain strong for years. This could mean the cost of biogenerics may not significantly drop within the first decade of their approval.

View Full Article in:

Drug Topics